Attached files
| file | filename |
|---|---|
| EX-12.1 - EXHIBIT 12.1 RATIO - PROGENICS PHARMACEUTICALS INC | ex12_112312014htm.htm |
| EX-23.1 - EXHIBIT 23.1 CONSENT OF ERNST & YOUNG LLP - PROGENICS PHARMACEUTICALS INC | ex23_112312014.htm |
| EX-32.1 - EXHIBIT 32.1 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex32_112312014.htm |
| EX-31.1 - EXHIBIT 31.1 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex31_112312014.htm |
| EX-31.2 - EXHIBIT 31.2 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex31_212312014.htm |
| EXCEL - IDEA: XBRL DOCUMENT - PROGENICS PHARMACEUTICALS INC | Financial_Report.xls |
| 10-K - PROGENICS PHARMACEUTICALS INC | form10_k12312014.htm |
| EX-32.2 - EXHIBIT 32.2 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex32_212312014.htm |
Exhibit 21.1
Progenics Pharmaceuticals, Inc.
Subsidiaries
|
Name
|
|
Jurisdiction of Incorporation
|
|
|
|
|
|
Excelsior Life Sciences Ireland Limited
|
|
Ireland
|
|
Molecular Insight Pharmaceuticals, Inc.
|
|
Delaware
|
|
Molecular Insight Limited*
|
|
England and Wales
|
|
Progenics Life Sciences Limited
|
|
England and Wales
|
|
Progenics Pharmaceuticals Nevada, Inc.
|
|
Nevada
|
|
PSMA Development Company LLC
|
|
Delaware
|
|
|
|
|
|
* Subsidiary of Molecular Insight Pharmaceuticals, Inc.
|
|
|